Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Apr 06, 2024 11:01am
120 Views
Post# 35974743

Mdjbrown...Apotex IS a an export doorway to China, NO DOUBT.

Mdjbrown...Apotex IS a an export doorway to China, NO DOUBT.1997...therefore already well established in China but keep reading further below.  Apotex,
working with LABS could export generic Epidiolex to China and that market dwarfs the
U.S. market.    You brought forth in the legal post that Apotex is a defendant and Apotex
can only source the FDA approved API from Medipharm Labs.   Add to the 'regular' 
drugs new classes of 'anti virals', China knows COVID all too well....even I can't come up with a true unlocked value of what LABS stock is worth.   I say this VERY SERIOUSLY, LABS could be a $100 per share rocket!  It's happened before when you have a pseudo monopoly from the starting line. 

Apotex Opens Office In China

 

15-10-1997 Print

Apotex Opens Office In China

 

- Apotex of Canada has opened its first representative office inChina, in Beijing, according to the China Daily Business Weekly.


 

FDA authorizes CISplatin importation from China

 



Due to the critical shortage of CISplatin, the US Food and Drug Administration (FDA) has authorized Qilu Pharmaceutical, in conjunction with its distributor Apotex,


With a presence in more than 75 countries and territories, Apotex makes a world of difference! Apotex has Research & Development, Supply, and Distribution hubs in Canada, the United States, Mexico, and India, with offices, affiliates and distributors in Central America, South America, Europe, the Middle East, and China. Our roots are in Canada, but our impact is global, ensuring accessible medicines wherever you may be.

<< Previous
Bullboard Posts
Next >>